GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » Retained Earnings

Pilulka Lekarny AS (XPRA:PINK) Retained Earnings : Kč-553 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Pilulka Lekarny AS's retained earnings for the quarter that ended in Dec. 2024 was Kč-553 Mil.

Pilulka Lekarny AS's quarterly retained earnings declined from Dec. 2022 (Kč-251 Mil) to Dec. 2023 (Kč-426 Mil) and declined from Dec. 2023 (Kč-426 Mil) to Dec. 2024 (Kč-553 Mil).

Pilulka Lekarny AS's annual retained earnings declined from Dec. 2022 (Kč-251 Mil) to Dec. 2023 (Kč-426 Mil) and declined from Dec. 2023 (Kč-426 Mil) to Dec. 2024 (Kč-553 Mil).


Pilulka Lekarny AS Retained Earnings Historical Data

The historical data trend for Pilulka Lekarny AS's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pilulka Lekarny AS Retained Earnings Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
-164.04 -188.42 -251.09 -425.77 -552.59

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings -164.04 -188.42 -251.09 -425.77 -552.59

Pilulka Lekarny AS Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Pilulka Lekarny AS  (XPRA:PINK) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Pilulka Lekarny AS Business Description

Traded in Other Exchanges
N/A
Address
Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS Headlines

From GuruFocus

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor 02-02-2023

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-31-2022